Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01433731
What this trial is testing

Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Lymphoma, T-Cell, Cutaneous
TetraLogic Pharmaceuticals 18
Early research (Phase 1)Study completedNCT02464605
What this trial is testing

Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels

Who this might be right for
Gout
Selecta Biosciences, Inc. 22
Early research (Phase 1)Study completedNCT05490095
What this trial is testing

Randomized Crossover of SVG101(Dispersible Tab. of Everolimus) and Afinitor 5mg in Healthy Adults

Who this might be right for
Pharmacokinetics
Sovargen 26
Testing effectiveness (Phase 2)Study completedNCT03411161
What this trial is testing

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerMetastatic Triple Negative Breast Cancer
Institut de Recherches Internationales Servier 22
Early research (Phase 1)Study completedNCT01285388
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

Who this might be right for
Metabolic SyndromeObesity
Yungjin Pharm. Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT01724086
What this trial is testing

Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Janssen R&D Ireland 90
Early research (Phase 1)Study completedNCT02075073
What this trial is testing

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects

Who this might be right for
Healthy
Samsung Bioepis Co., Ltd. 109
Early research (Phase 1)Study completedNCT00372983
What this trial is testing

Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

Who this might be right for
Hepatitis C
Cellectar Biosciences, Inc. 30
Early research (Phase 1)Study completedNCT00417261
What this trial is testing

Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.

Who this might be right for
Healthy
Novartis 65
Early research (Phase 1)Study completedNCT05468060
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetic Characteristics of PA1010 in Healthy Subjects

Who this might be right for
Chronic HBV Infection
Zhejiang Palo Alto Pharmaceuticals, Inc. 80
Early research (Phase 1)Study completedNCT03722823
What this trial is testing

A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects

Who this might be right for
Hepatic Impairment
Seagen Inc. 37
Early research (Phase 1)Active Not RecruitingNCT07295496
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011

Who this might be right for
Acute Gout Flare
Innovent Biologics (Suzhou) Co. Ltd. 64
Early research (Phase 1)UnknownNCT02579473
What this trial is testing

Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Who this might be right for
Parkinson's Disease
Serina Therapeutics 20
Early research (Phase 1)Not Yet RecruitingNCT07783269
What this trial is testing

A Basket Study of CTA313 in Participants With Active Autoimmune Diseases

Who this might be right for
Systemic Lupus Erthematosus (SLE)Progressive Multiple Sclerosis (PMS)Autoimmune Encephalitis
Imviva Bio 81
Early research (Phase 1)Study completedNCT01226693
What this trial is testing

A Study In Healthy Volunteers To Assess The Safety, Tolerability, And Relative Oral Bioavailability Of Three Formulations Of PH-797804

Who this might be right for
Healthy
Pfizer 18
Early research (Phase 1)UnknownNCT02614352
What this trial is testing

Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects

Who this might be right for
Healthy Male Subjects
Ahn-Gook Pharmaceuticals Co.,Ltd 60
Testing effectiveness (Phase 2)Study completedNCT06144749
What this trial is testing

A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)

Who this might be right for
Anemia, Sickle Cell
Hillhurst Biopharmaceuticals, Inc. 13
Early research (Phase 1)Study completedNCT01550458
What this trial is testing

Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers

Who this might be right for
Healthy
Cavion, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00778518
What this trial is testing

Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).

Who this might be right for
Growth Hormone Deficiency
Ambrx, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT05170958
What this trial is testing

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
Nanjing Leads Biolabs Co.,Ltd 396
Next Page